![Michael Diefenbeck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 31/08/2026
Michael Diefenbeck is currently the Chief Medical Officer & EVP-Medical Affairs at BONESUPPORT HOLDING AB. He holds a doctorate degree from Ludwig-Maximilians-Universität München and Friedrich Schiller University of Jena, which was conferred in 2011.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BONESUPPORT HOLDING AB 0,16 % | 31/12/2025 | 108.160 ( 0,16 % ) | 2 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BONESUPPORT HOLDING AB | Director Técnico/Científico/I+D | 01/04/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Friedrich Schiller University of Jena
 Friedrich Schiller University of Jena Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BONESUPPORT HOLDING AB
 BONESUPPORT HOLDING AB Medical SpecialtiesHealth Technology Develops and sells injectable, synthetic ceramic bone substitutes and injection accessories | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
